Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Regulatory News (REDX)

  • There is currently no data for REDX
Date   Source Headline
31st Jul 20177:00 amRNSDisposal of BTK inhibitor drug development program
23rd Jun 20172:38 pmRNSMHRA approval of Clinical Trial Application
22nd Jun 20177:00 amRNSUpdate on Suspension of Trading
24th May 20176:35 pmRNSStatement re. Suspension
24th May 20174:35 pmRNSSuspension - Redx Pharma plc
17th May 20177:00 amRNSInterim results for six months ended 31 March 2017
15th May 20177:00 amRNSPreclinical efficacy data presented on RXC005
4th May 20177:00 amRNSNotice of Interim Results
20th Apr 201711:20 amRNSResult of AGM
20th Apr 20177:00 amRNSAppointment of Chairman
7th Apr 20173:56 pmRNSNotice of Annual General Meeting
3rd Apr 20177:15 amRNSHardman: CARB-X - new strategic collaboration
30th Mar 20174:03 pmRNSRedx Pharma awarded US$1 million grant by CARB-X
21st Mar 20179:05 amRNSFinal Results Year Ended 30 September 2016
7th Mar 20174:33 pmRNSHolding(s) in Company
3rd Mar 20172:35 pmRNSHolding(s) in Company
3rd Mar 20172:27 pmRNSHolding(s) in Company
3rd Mar 20172:17 pmRNSHolding(s) in Company
2nd Mar 20175:01 pmRNSHolding(s) in Company
2nd Mar 20177:50 amRNSRedx presentations at AACR 2017
28th Feb 201710:35 amRNSResult of General Meeting and Issue of Equity
27th Feb 20175:50 pmRNSResult of Open Offer
10th Feb 20171:00 pmRNSResult of Placing
9th Feb 20177:00 amRNSAccelerated Book Build
8th Feb 20176:30 pmRNSAccelerated Book Build
27th Jan 20177:00 amRNSGrowing opportunity for Porcupine inhibitors
6th Dec 20167:00 amRNSReversible BTK poster at ASH meeting
30th Nov 20167:00 amRNSRXC004 pre-clinical profile
16th Nov 20163:22 pmRNSHolding(s) in Company
4th Nov 20167:00 amRNSReversible BTK data at ASH meeting
20th Oct 20167:00 amRNSDevelopment candidate chosen for leukaemia program
11th Oct 20169:32 amRNSExercise of Options and Total Voting Rights
27th Sep 20167:00 amRNSDiscovery of breakthrough antibiotic compounds
23rd Sep 20164:07 pmRNSHolding(s) in Company
21st Sep 20168:50 amRNSHolding(s) in Company
19th Sep 20167:00 amRNSRe: Porcupine inhibitor and cancer immunotherapy
16th Sep 201611:31 amRNSHolding(s) in Company
14th Sep 201610:47 amRNSHolding(s) in Company
8th Sep 20167:00 amRNSBoard & Senior Management Changes
6th Sep 20167:00 amRNSSupply agreement for expected clinical trial
8th Aug 201610:55 amRNSHardman Research: Moving to clinic, rising value
17th Jun 201612:15 pmRNSRedx to present at ASM Microbe 2016 Conference
24th May 20167:00 amRNSProof of concept with key oncology lead
24th May 20167:00 amRNSHalf-year Report
19th May 20167:00 amRNSRe Review on Antimicrobial Resistance
9th May 20167:00 amRNSBoard Appointment
26th Apr 20163:37 pmRNSHolding(s) in Company
19th Apr 20164:52 pmRNSHolding(s) in Company
18th Apr 20167:00 amRNSHolding(s) in Company
15th Apr 20165:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.